Ingredient-type: Boron Compounds
✉ Email this page to a colleague
Drugs of Ingredient-Type: Boron Compounds
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212215-001 | May 7, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211963-001 | Feb 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alembic | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212188-001 | Oct 21, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cipla | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212224-001 | Feb 9, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |